A Prospective Comparative Study of the Toxicity Profile of 5-Flurouracil, Adriamycin, Cyclophosphamide Regime VS Adriamycin, Paclitaxel Regime in Patients with Locally Advanced Breast Carcinoma
Introduction: A 5-flurouracil, Adriamycin, Cyclophosphamide (FAC) and Adriamycin, Paclitaxel (AT) are two popular chemotherapeutic regimens for treatment of breast carcinoma. The most time tested and popular regimen is FAC. It is extensively studied for efficacy and toxicity. But data regarding...
Main Authors: | Jihana Shajahan, Pradeep Sadasivan Pillai, Krishnan Nair Lalithamma Jayakumar |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2015-12-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://jcdr.net/articles/PDF/6864/15939_CE[Ra1]_F(GH)_PF1(Ek_Om)_PFA(AK)_PF2(PAG).pdf |
Similar Items
-
EFFECT OF SEVOFLURANE EXPOSURE ON ADRIAMYCIN-INDUCED INJURIES TO MYOCYTES
by: Li-hua Fan, et al.
Published: (2014-01-01) -
Preventive role of carvedilol in adriamycin-induced cardiomyopathy
by: Rajesh Jhorawat, et al.
Published: (2016-01-01) -
The cost-effectiveness of neoadjuvant chemotherapy in women with locally advanced breast cancer: Adriamycin and cyclophosphamide in comparison with paclitaxel and gemcitabine
by: Javad Javan-Noughabi, et al.
Published: (2018-01-01) -
Attenuation of neuroinflammation reverses Adriamycin-induced cognitive impairments
by: Barrett D. Allen, et al.
Published: (2019-11-01) -
Astragalus Polysaccharide Promotes Adriamycin-Induced Apoptosis in Gastric Cancer Cells
by: Song J, et al.
Published: (2020-04-01)